CS, C., V, K., DM, G., RJ, C., JD, L., & TM, W. (2021). In Vivo Pharmacodynamic Method to Assess Complement C5a Receptor Antagonist Efficacy. ACS pharmacology & translational science, 5(1), 41. https://doi.org/10.1021/acsptsci.1c00227
Chicago Style (17th ed.) CitationCS, Cui, Kumar V, Gorman DM, Clark RJ, Lee JD, and Woodruff TM. "In Vivo Pharmacodynamic Method to Assess Complement C5a Receptor Antagonist Efficacy." ACS Pharmacology & Translational Science 5, no. 1 (2021): 41. https://doi.org/10.1021/acsptsci.1c00227.
MLA (9th ed.) CitationCS, Cui, et al. "In Vivo Pharmacodynamic Method to Assess Complement C5a Receptor Antagonist Efficacy." ACS Pharmacology & Translational Science, vol. 5, no. 1, 2021, p. 41, https://doi.org/10.1021/acsptsci.1c00227.